SPHERE: NHMRC Centre of Research Excellence in Sexual and Reproductive Health for Women in Primary Care, October 2022 The primary objective of the webinar is to provide general practitioners, practice nurses and community pharmacists with the support required to initiate EMA services in their area. This will be undertaken by providing an overview of: • the context of South Australian legislation...
Hepatitis C In NSP Settings: free training
ASHM, June 2022 This free training aims to provide participants with the confidence to initiate conversations around hepatitis C in the needle and syringe program (NSP) setting. Frontline workers in NSP settings have a crucial and unique role to play in eliminating hepatitis C. Every day you’re talking to people who might be living with hepatitis C, and in these conversations you can support...
Coronavirus disease (COVID-19), HIV & hepatitis C: What you need to know
CATIE (Canada), 17 March 2020 An HIV-positive person on effective treatment is not expected to be at higher risk of becoming seriously ill with COVID-19 A person with untreated HIV or a low CD4+ cell count may be at higher risk of becoming seriously ill with COVID-19 People with HIV or hepatitis C are more likely to have other conditions that carry a greater risk of becoming seriously ill with...
Emergency contraception awareness in an at‐risk population
Hope, D. L., Hattingh, L. and King, M. A. (2019) J Pharm Pract Res. doi:10.1002/jppr.1554 Background Consumer awareness of emergency contraception is generally poor. School leavers (schoolies) engage in risky behaviours, including casual sex and alcohol and drug consumption. Aim The aim of this study was to explore the awareness of an at‐risk population of schoolies regarding the use and...